This page shows the latest CTRS news and features for those working in and with pharma, biotech and healthcare.
registered in the UK will continue to be registered after Brexit, and a pledge to align with the forthcoming EU Clinical Trial Regulation (CTR), even though it will come into effect
The EU is set to introduce a major update to clinical trials practice in 2019 and 2020 – the Clinical Trials Regulation (CTR).
The government has confirmed that the existing 2004 Regulations will remain in force, but that its long-awaiting updated version, the new EU Clinical Trials Regulation (. CTR. ) 536/2014 will not ... CTR. without delay when it does come into force,
CTR but also other issues such as impacts on trade, access to new medicines, data, funding and the workforce. ... The UK government should continue to seek full regulatory alignment with the [CTR],” says CRUK’s report.
This can be seen in the court's case law, which held that 'off-label prescribing is the sole responsibility of the prescribing physicians' (CTRS judgment) in 'individual situations justified by
Laboratoires CTRS bagged a positive opinion for Neofordex, a 40mg tablet formulation of the corticosteroid dexamethasone, as a treatment for multiple myeloma.
More from news
Approximately 2 fully matching, plus 6 partially matching documents found.
GDPR and the Clinical Trials Regulation (CTR) (which entered into force in 2014 and is expected to become applicable in 2020). ... The CTR’s objective is to harmonise the rules for conducting clinical trials throughout the EU.
Regulation 536/2014 (EU CTR Article 37).
More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.
The advantage is a more interested audience, more engaged with your advertisement, meaning higher CTR% and more conversions.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...